Press Release |
The National Organization for Rare Disorders (NORD) Names Peter Saltonstall New President
* Reuters is not responsible for the content in this press release.
Senior health care professional looks forward to building on NORD's 25 years of advocacy and support for those with rare disorders WASHINGTON--(Business Wire)-- The National Organization for Rare Disorders (NORD) announced today that its board has unanimously selected Peter Saltonstall to be the organization's new president and chief executive officer. The appointment comes as NORD celebrates its 25th anniversary and the 25th anniversary of the landmark Orphan Drug Act which provides incentives for development of therapies for people with "orphan" diseases affecting 200,000 or fewer people in this country. With 30 years in the health care field, Saltonstall brings a wealth of experience to NORD and a commitment to improving health systems to benefit patients. Saltonstall held senior executive positions within a number of major academic medical centers and organizations, including Harvard's Brigham and Women's Hospital, Tufts-New England Medical Center, St. Elizabeth's Medical Center of Boston and Harvard's Risk Management Foundation and led an organizational team working with 29 different community groups to relocate and build a $459 million new Medical Center in Boston. Devoted to improving patient safety, he was a founding member of three health service oriented businesses that developed computerized patient safety reporting systems. He also played a major role on Capitol Hill in the development of the Patient Safety Act of 2005, which has dramatically improved the reporting of events that adversely affect patients. As the leader of NORD, he brings this same commitment to improving health care and development of new therapies for the more than 6,000 rare diseases which in aggregate affect 25 million people in this country. "We have accomplished much over the past 25 years, but there is still a lot of work to do," said Abbey Meyers, the founder of NORD, who retired as its president in April. "Peter's extensive experience working with a variety of different stakeholders on complex issues will be a great asset to NORD in advancing the cause of the millions of Americans who suffer from rare disorders." After being notified of his selection by the Board of Directors following a nationwide search, Saltonstall talked about his admiration for NORD's work, his personal experience with rare disorders and his hopes for the future, "I am honored to take on this responsibility and excited about the opportunities to further strengthen the crucial support NORD provides to patients and families affected by rare disorders." "The Board has every confidence that Peter's leadership skills and his extensive patient advocacy, policy, health care management and development experience will advance NORD's mission, "said Dr. Carolyn Asbury, Chair of the NORD Board of Directors. " He comes to NORD prepared to build on its accomplishments and to chart its future on behalf of people with rare diseases," she said. Peter Saltonstall lives in the Washington D.C. metropolitan area. About NORD The National Organization for Rare Disorders (NORD), a 501(c)3 organization, is a unique federation of voluntary health organizations dedicated to helping people with rare "orphan" diseases and assisting the organizations that serve them. A rare or "orphan" disease affects fewer than 200,000 people in the United States. There are more than 6,000 rare disorders that, taken together, affect approximately 25 million Americans. For twenty-five years, NORD has served as the primary non-governmental clearinghouse for information on rare disorders. NORD is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service. (www.rarediseases.org) Bell Pottinger USA Tom Nadolski, 617-226-7195 / 781-354-7436 firstname.lastname@example.org Copyright Business Wire 2008